Suppr超能文献

肺癌中N1期疾病的预后意义

Prognostic significance of N1 disease in carcinoma of the lung.

作者信息

Martini N, Flehinger B J, Nagasaki F, Hart B

出版信息

J Thorac Cardiovasc Surg. 1983 Nov;86(5):646-53.

PMID:6314060
Abstract

From 1973 to 1981, 75 patients with T1 N1 M0 and T2 N1 M0 disease had a complete, potentially curative resection with mediastinal lymph node dissection. Thirty-eight had adenocarcinomas, 36 epidermoid cancer and one large cell carcinoma. Surgical treatment consisted of lobectomy in 54, sleeve lobectomy in three, and pneumonectomy in 18. Two patients died postoperatively. Of 17 patients with T1 N1 disease, 14 had no further treatment and three received postoperative radiation and/or chemotherapy; the 5 year cumulative survival rate of these patients was 56%. There were 58 patients with T2 N1 disease. Forty-five had no further treatment and 13 received postoperative radiation and/or chemotherapy; the 5 year cumulative survival rate of these patients was 48%. The overall incidence of local and regional recurrence was low, and the brain was the most frequent site of recurrence. Factors influencing recurrence were histology and proximity of the tumor to hilum. The specific nodes involved, the number of nodes affected, and the extent of involvement within the nodes had no observed effect on survival. There was no observed improvement in survival with the use of adjuvants. However, survival was significantly poorer in patients with visceral pleural involvement.

摘要

1973年至1981年期间,75例T1 N1 M0和T2 N1 M0期疾病患者接受了纵隔淋巴结清扫的根治性切除手术。其中38例为腺癌,36例为鳞癌,1例为大细胞癌。手术治疗包括54例行肺叶切除术,3例行袖状肺叶切除术,18例行全肺切除术。2例患者术后死亡。17例T1 N1期疾病患者中,14例未接受进一步治疗,3例接受了术后放疗和/或化疗;这些患者的5年累积生存率为56%。有58例T2 N1期疾病患者。45例未接受进一步治疗,13例接受了术后放疗和/或化疗;这些患者的5年累积生存率为48%。局部和区域复发的总体发生率较低,脑是最常见的复发部位。影响复发的因素是组织学类型和肿瘤与肺门的距离。所累及的特定淋巴结、受累淋巴结的数量以及淋巴结内的受累范围对生存率无明显影响。未观察到使用辅助治疗可提高生存率。然而,脏层胸膜受累的患者生存率明显较差。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验